Frequency Therapeutics said its hearing loss drug candidate failed to beat a placebo in its second mid-stage clinical trial. The biotech is now focusing its regenerative medicine platform on the development of a multiple sclerosis drug not expected to reach the clinic until next year.
Nearly 25% of working-age adults have hearing issues, and 60% percent of people with hearing loss are below retirement age. But 50% of those with untreated hearing loss do not have their hearing professionally checked before the age of 60. Tuned is trying to change that by offering its platform to employers as a benefit.
Alan Murray on improving access for medical transportation.
The idea behind the partnership is that consumers will be able to use their Android devices without relying on an intermediate tool for streaming audio to their hearing aids.
A bill introduced by Sens. Elizabeth Warren (D-Massachusetts) and Rand Paul (R-Kentucky) in March would allow patients to visit an audiologist to get a hearing test to diagnose a hearing problem without first being referred by a physician or nurse practitioner.
Oticon, the company behind the Opn hearing aid, also has a hearing aid app called HearingFitness. It functions somewhat like a fitness tracker and gives users advice and encouragement about their hearing well-being.
It’s likely that lower-end versions will be made available over the coming years, but how long is that?
CEO and neuroscientist Dr. Iftach Dolev on how the new device can bring a powerful tool to psychiatrists and neurologists alike.